512 related articles for article (PubMed ID: 35684353)
21. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract][Full Text] [Related]
22. Current status and future perspectives of PI3K and mTOR inhibitor as anticancer drugs in breast cancer.
Zhang X; Li XR; Zhang J
Curr Cancer Drug Targets; 2013 Feb; 13(2):175-87. PubMed ID: 23215724
[TBL] [Abstract][Full Text] [Related]
23. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.
Sarwar M; Syed Khaja AS; Aleskandarany M; Karlsson R; Althobiti M; Ødum N; Mongan NP; Dizeyi N; Johnson H; Green AR; Ellis IO; Rakha EA; Persson JL
Oncogene; 2019 Jan; 38(3):375-389. PubMed ID: 30104711
[TBL] [Abstract][Full Text] [Related]
24. Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment.
Narayanankutty A
Recent Pat Anticancer Drug Discov; 2020; 15(3):188-199. PubMed ID: 32914720
[TBL] [Abstract][Full Text] [Related]
25. Estrogen Receptor-Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance.
Brufsky AM; Dickler MN
Oncologist; 2018 May; 23(5):528-539. PubMed ID: 29352052
[TBL] [Abstract][Full Text] [Related]
26. Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling.
Grunt TW; Mariani GL
Curr Cancer Drug Targets; 2013 Feb; 13(2):188-204. PubMed ID: 23215720
[TBL] [Abstract][Full Text] [Related]
27. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.
Chamcheu JC; Roy T; Uddin MB; Banang-Mbeumi S; Chamcheu RN; Walker AL; Liu YY; Huang S
Cells; 2019 Jul; 8(8):. PubMed ID: 31370278
[TBL] [Abstract][Full Text] [Related]
28. Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action.
Safdari Y; Khalili M; Ebrahimzadeh MA; Yazdani Y; Farajnia S
Pharmacol Res; 2015 Mar; 93():1-10. PubMed ID: 25533812
[TBL] [Abstract][Full Text] [Related]
29. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways.
Kilbas PO; Akcay IM; Doganay GD; Arisan ED
Mol Biol Rep; 2019 Feb; 46(1):847-860. PubMed ID: 30661182
[TBL] [Abstract][Full Text] [Related]
30. The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress.
Bahrami A; Khazaei M; Shahidsales S; Hassanian SM; Hasanzadeh M; Maftouh M; Ferns GA; Avan A
J Cell Biochem; 2018 Jan; 119(1):213-222. PubMed ID: 28513879
[TBL] [Abstract][Full Text] [Related]
31. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
Sylvester PW; Ayoub NM
Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
[TBL] [Abstract][Full Text] [Related]
32. Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells.
Erkisa M; Sariman M; Geyik OG; Geyik C; Stanojkovic T; Ulukaya E
Curr Med Chem; 2022; 29(4):741-783. PubMed ID: 34182899
[TBL] [Abstract][Full Text] [Related]
33. Protein kinases as targets for developing anticancer agents from marine organisms.
Qiao G; Bi K; Liu J; Cao S; Liu M; Pešić M; Lin X
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129759. PubMed ID: 33038451
[TBL] [Abstract][Full Text] [Related]
34. Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways.
Almatroodi SA; Almatroudi A; Khan AA; Rahmani AH
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298670
[TBL] [Abstract][Full Text] [Related]
35. Evening Primrose Oil Enhances Tamoxifen's Anticancer Activity against Breast Cancer Cells by Inducing Apoptosis, Inhibiting Angiogenesis, and Arresting the Cell Cycle.
Abd-Alhaseeb MM; Massoud SM; Elsayed F; Omran GA; Salahuddin A
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458590
[TBL] [Abstract][Full Text] [Related]
36. Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine.
Ansari JA; Malik JA; Ahmed S; Bhat FA; Khanam A; Mir SA; Abouzied AS; Ahemad N; Anwar S
Pharmacology; 2023; 108(6):504-520. PubMed ID: 37748454
[TBL] [Abstract][Full Text] [Related]
37. Effects of propolis and its bioactive components on breast cancer cell pathways and the molecular mechanisms involved.
Masadah R; Ikram D; Rauf S
Breast Dis; 2021; 40(S1):S15-S25. PubMed ID: 34057114
[TBL] [Abstract][Full Text] [Related]
38. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
39. Curcumin in Treating Breast Cancer: A Review.
Wang Y; Yu J; Cui R; Lin J; Ding X
J Lab Autom; 2016 Dec; 21(6):723-731. PubMed ID: 27325106
[TBL] [Abstract][Full Text] [Related]
40. Natural products for treating colorectal cancer: A mechanistic review.
Huang XM; Yang ZJ; Xie Q; Zhang ZK; Zhang H; Ma JY
Biomed Pharmacother; 2019 Sep; 117():109142. PubMed ID: 31238258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
